Review

You have free access to this content

The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia

  1. Carolyn Owen1,*,
  2. Jude Fitzgibbon2,
  3. Peter Paschka3

Article first published online: 9 DEC 2009

DOI: 10.1002/hon.931

Issue

Hematological Oncology

Hematological Oncology

Volume 28, Issue 1, pages 13–19, March 2010

Additional Information

How to Cite

Owen, C., Fitzgibbon, J. and Paschka, P. (2010), The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia. Hematol. Oncol., 28: 13–19. doi: 10.1002/hon.931

Author Information

  1. 1

    Division of Hematology and Hematological Malignancies, University of Calgary, Calgary, Canada

  2. 2

    Department of Medical Oncology, Barts and the London School of Medicine, London, UK

  3. 3

    Department of Hematology, Oncology, Rheumatology and Infectious Diseases, University Hospital of Ulm, Ulm, Germany

*Division of Hematology & Hematological Malignancies, 601A South Tower, Foothills Medical Centre, 1403-29th Street NW, Calgary, Alberta, T2N 2T9, Canada.

Publication History

  1. Issue published online: 15 MAR 2010
  2. Article first published online: 9 DEC 2009
  3. Manuscript Accepted: 11 SEP 2009
  4. Manuscript Received: 7 SEP 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (116K)

No citations currently available for this article.

Get PDF (116K)